Stanford University Team Wins Award for Drug-Delivery Catheter Design - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Stanford University Team Wins Award for Drug-Delivery Catheter Design


The Wyshbone drug-delivery catheter, which continuously applies lidocaine to the throat during breathing tube insertion, won second prize last week in the National Collegiate Inventors and Innovators Alliance (NCIIA) Biomedical Engineering Innovation, Design, and Entrepreneurship Award (BMEidea) contest, NCIIA announced in a press release. The targeted drug-delivery approach allows clinicians to minimize sedation and its accompanying side effects.

Rush Bartlett II, PhD, and Ryan Van Wert, MD, designed the device as part of their participation in Stanford’s Biodesign Program, which places fellows in a local hospital to identify medical or operational problems and build prototypes to provide solutions. Bartlett and Van Wert founded medical-device start-up AWAIR, which received initial funding from NCIIA.

The NCIIA helps student and faculty entrepreneurs bring concepts to commercialization. BMEidea is an annual competition with awards presented each year at the MD&M East Medical Device Trade Show and Convention. 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race

Click here